Institutional Ownership Neuro Sense Therapeutics Ltd. (NRSN)
This table provides information about the institutional ownership of Neuro Sense Therapeutics Ltd. (NRSN). We have compiled data on the 9 institutions that hold shares in the stock, with a total of 167,126 shares, which have been reported (via 13F filing form) to have a value of $142,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 13, 2024 Q1 2024 |
71,100
shares
|
$60,435
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Meitav Dash Investments LTD
|
May 01, 2024 Q1 2024 |
50,000
shares
|
$42,500
0.0% of portfolio
|
Q1 2024
Reduced 47.37%
|
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2024 Q1 2024 |
19,581
shares
|
$16,643
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
11,963
shares
|
$10,168
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Ubs Group Ag
|
May 13, 2024 Q1 2024 |
11,928
shares
|
$10,138
0.0% of portfolio
|
Q1 2024
Added 117.03%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
1,500
shares
|
$1,275
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Cwm, LLC
|
Apr 05, 2024 Q1 2024 |
1,000
shares
|
$850
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Qube Research & Technologies LTD
London, X0 |
May 14, 2024 Q1 2024 |
54
shares
|
$45
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Apr 30, 2024 Q1 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q1 2024
New holding
|